Wide range of suitable people, more advantageous prices, stable supply

　　The domestic HPV vaccine is here, about?

　　Our reporter Zhao Chen

　　Reading tips

　　The first batch of domestically produced HPV vaccines has landed, and multiple provinces and cities in China can make appointments for vaccination. The industry believes that the cheaper domestic vaccines are expected to increase the HPV vaccine coverage rate and reach more women.

　　As a vaccine to prevent cancer, HPV vaccine (human papillomavirus vaccine) has always been a "net red" vaccine that has received much social attention. A few days ago, as the domestic bivalent HPV vaccine with more competitive prices and stable supply has "fallen into the ground", women have more choices for vaccination.

　　"Net Red" vaccine has a domestic version

　　"The price is lower and it may be better to make an appointment. Should I call?" Zhang Ningning, 32, works in Zhanjiang, Guangdong. In early May, a news made her pay attention to the HPV vaccine again.

　　On May 18, the country's first domestically made bivalent HPV vaccine (trade name "Xin Ke Ning") was vaccinated in Hubei Maternal and Child Health Hospital, and a 10-year-old Wuhan girl became the first vaccinator in the country. The listing of "Xin Kening" broke the situation of relying on imported vaccines.

　　In an interview, Lei Chengzhi, deputy chief physician of the Department of Gynecology and Oncology at the National Cancer Center and the Cancer Hospital of the Chinese Academy of Medical Sciences, said in an interview that human papillomavirus is considered to be the culprit causing cervical cancer and other cancers. Both men and women may be infected, suitable for age and suitable People who get HPV vaccine can prevent related cancers.

　　"Vaccination can prevent cancer. After this information spread, as long as I met a female friend, I was discussing whether to get the HPV vaccine, where to go, how to make an appointment." In Zhang Ningning's view, the HPV vaccine is indeed It is a "net red" vaccine, and its topic has continued for a long time after entering the domestic market.

　　According to data from the China Food and Drug Administration, based on 356 million women of the appropriate age and 3 doses per person, my country's HPV vaccine market gap exceeds 1 billion.

　　At present, the legally listed HPV vaccines in my country include four types of imported bivalent vaccines, imported quadrivalent vaccines, imported nine-valent vaccines, and domestic two-valent vaccines "Xin Kening". Among them, the price of "Xin Ke Ning" is 329 yuan/needle. From May, the first batch of 93643 vaccines can be scheduled for vaccination.

　　Relevant departments said that due to the difference in the procurement time of vaccines in different regions, it is recommended to consult the community health service center or the township health center for vaccination clinics.

　　"The price is cheaper, there are refreshments"

　　At present, Hubei, Xinjiang, Jilin, Yunnan, Jiangsu, Shandong and other regions as the first batch of vaccination sites have started to use "Xin Kening". On social media platforms, some netizens began to ask questions about how to schedule vaccination and vaccination costs. For some young women, after determining their willingness to vaccinate, "Where to get injections" is the most concerned issue.

　　"Worker Daily" reporter inquired on a vaccination appointment mini-program that many cities including Wuhan and Kunming already have domestic HPV bivalent vaccination services. As of June 3, taking Wuhan as an example, a total of 11 institutions on the small program provide appointment entrances for domestic vaccination clinics, community health service stations and other institutions, but there are also multiple interfaces showing out of stock or lack of vaccines; In Kunming, there are 7 institutions with appointment entrances on the mini-program.

　　At present, "Xin Kening" has been "landed" in Yunnan Baoshan, Dali, Kunming and many other areas, and many women have queued up for registration and vaccination in institutions such as community service centers.

　　"The price is much cheaper than imported vaccines, and there are refreshments." said Chen Yi, who works in Beijing. On June 4, she called the nearest community hospital for inquiries and was told that there was no domestically produced HPV vaccine and was affected by the epidemic. It is necessary to wait for the phone to notify the imported HPV tetravalent vaccine of the appropriate age. She decided to "wait and see."

　　From "one needle is hard to find" to batch listing

　　Speaking of the HPV vaccine, Guan Yunshan, who lives in Beijing, ridiculed himself as the first "crab eater." In 2017, when she learned that the imported HPV vaccine had entered the domestic market, she called the community hospital near her home. On the first working day after the Spring Festival in 2018, she was vaccinated with the first imported HPV quadrivalent vaccine as she wished. "On the third day, my friend will go and there will be no vaccine."

　　"One needle is hard to find" is how many people feel about the HPV vaccine. In 2019, Peng Xin, who had just graduated from university, waited for half a year before arranging to import the HPV nine-valent vaccine, which caught up with the 26-year-old "last train."

　　In addition, the relatively expensive price of imported HPV vaccines also made some women hesitate to fight or not. "I'm in my 30s and spent thousands of dollars to vaccinate. I don't know if the effect is good or not." Zhang Ningning told reporters.

　　In her view, compared with the ups and downs of HPV vaccination around 2018, the pace of domestically made vaccines on the market is more stable. "After all, those who are particularly enthusiastic are basically vaccinated. Those of us who are still hesitating may choose more rationally."

　　Industry insiders said that with the mass market of domestic vaccines, it can better relieve the tight supply of domestic HPV vaccines. At the same time, the cheaper domestic vaccines are expected to increase the coverage of HPV vaccines and cover more women.

　　(According to the request of the interviewee, the name of the person in the text is pseudonymized)